You are here: Industry Insights > GlobalData

News List

Pharma industry thinks high-risk groups should get priority for COVID-19 vaccine: GlobalData Poll expresspharma
July 29, 2020
High-risk groups include older patients, those with pre-existing conditions, at-risk ethnicities and healthcare workers.
Number of US COVID-19 clinical trials surpasses China: GlobalData expresspharma
July 28, 2020
Clinical trials in India also growing at a higher rate, and the country is now in fourth place for COVID-19 trials.
COVID-19 has pushed infectious disease drugs to be top CSAs: GlobalData expresspharma
July 27, 2020
COVID-19 may also be disrupting other therapy areas by reducing service agreements for other non-COVID-19 drugs.
China’s indigenously developed COVID-19 vaccines set to surprise the world: GlobalData expresspharma
July 21, 2020
China's Sinopharm and Sinovac (in collaboration with Brazil-based Butantan) have both reported encouraging results in the early phases of human testing for COVID-19.
Remdesivir treatment gains popularity in India, black marketing and price cuts to continue: GlobalData expresspharma
July 21, 2020
According to figures compiled by the CDSCO, India will be producing 20,000 vials per day by the end of July.
Healthcare industry reports deals worth US $8.2-bn in June’20: GlobalData expresspharma
July 09, 2020
In June 2020, the healthcare industry reported 87 deals worth US $8.2 billion as compared to last 12 months’ average (June 2019 to May 2020) of 64 deals worth US$17.7 billion.
Big bio/pharma companies sales bolstered by COVID-19: GlobalData expresspharma
July 02, 2020
This increase was due to stockpiling by people in preparation for reduced medical access in the lockdown.
Key pipeline advancements to propel myelodysplastic syndromes market to $2.4 bn by 2028: GlobalData expresspharma
June 29, 2020
Despite the recent surge of development within the MDS space, KOLs argue that the level of unmet need remained dire.
Over 2,000 clinical trials currently underway for COVID-19 therapies, finds study europeanpharmaceuticalreview
June 28, 2020
New findings have revealed that over 2,000 clinical trials are being conducted to test COVID-19 therapies while 583 companies are involved in treatment and vaccine development.
Small market cap companies more dependent on COVID-19 pipeline drug: GlobalData expresspharma
June 23, 2020
The small-cap bio/pharma companies without a COVID-19 drug, on average, declined by 19.4 per cent.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page